- Used for the rapid, qualitative detection of SARS-CoV-2 antigens. Designed to run on the Sofia 2 Fluorescent Immunoassay Analyzer, this CLIA-waived test provides automated, objective results in just 10 minutes
Uses
- Diagnostic Screening:
- Used by healthcare professionals in clinics, emergency departments, and long-term care facilities to test symptomatic patients within the first 6 days of symptom onset
- Serial Testing:
- Aids in diagnosing SARS-CoV-2 in symptomatic individuals when tested serially (at least twice over 3 days, with 48 hours between tests) or to confirm negative results
Features
- Advanced Technology:
- Uses immunofluorescence-based lateral flow technology, eliminating the subjectivity of a visual (eye-read) test
- Fast Turnaround:
- Delivers automated and objective results in approximately 10 minutes
- Dual Work Modes:
- Features "Walk Away" (batching) and "Read Now" (quick throughput) modes to easily adjust to fluctuating clinical testing volumes
- CLIA Waived:
- Simple to perform with minimal hands-on time, allowing it to be widely used in various point-of-care settings
- Integrated Connectivity:
- Can connect to Virena Data Management for automated data tracking, government reporting, and disease mapping
Benefits
- Efficiency:
- Rapid results support quick patient dispositioning and allow for "test-and-treat" strategies during the same office visit
- Objectivity:
- The Sofia 2 analyzer provides definitive objective readings, significantly reducing the margin of human error
- User-Friendly:
- Test kits include all necessary components (cassettes, pre-filled reagent tubes, swabs, and fixed-volume pipettes) for an easy, clean collection procedure
